Vaccine Slows Return of Pancreatic Cancer in Early Trial
THURSDAY, May 11, 2023 (HealthDay News) – A gene-targeted personalized vaccine may delay the return of pancreatic cancer according to a small, but promising, trial. The mRNA vaccine, which was tailored to the genetic makeup of each patient’s tumor, worked in half of those who received it during 18 monthsContinue Reading